Net profit of Shree Ganesh Biotech India declined 58.44% to Rs 0.32 crore in the quarter ended December 2025 as against Rs 0.77 crore during the previous quarter ended December 2024. Sales declined 95.14% to Rs 0.70 crore in the quarter ended December 2025 as against Rs 14.41 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales0.7014.41 -95 OPM %-7.143.26 - PBDT0.320.77 -58 PBT0.320.77 -58 NP0.320.77 -58 Powered by Capital Market - Live News

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 29 January 2026.Powered by Capital Market - Live News

Net profit of Shree Ganesh Biotech India declined 96.88% to Rs 0.01 crore in the quarter ended September 2025 as against Rs 0.32 crore during the previous quarter ended September 2024. Sales declined 61.11% to Rs 0.77 crore in the quarter ended September 2025 as against Rs 1.98 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales0.771.98 -61 OPM %-51.951.01 - PBDT0.010.32 -97 PBT0.010.32 -97 NP0.010.32 -97 Powered by Capital Market - Live News

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 8 November 2025.Powered by Capital Market - Live News

Shree Ganesh Biotech India announced that the Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live News